Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Colorectal Neoplasms 19Colonic Neoplasms 9Pancreatic Neoplasms 7Esophageal Neoplasms 7Stomach Neoplasms 6Rectal Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Adenocarcinoma Of Esophagus 5Ovarian Neoplasms 4Neoplasm Metastasis 4Cholangiocarcinoma 4Carcinoma, Non-Small-Cell Lung 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Neoplasms 3Endometrial Neoplasms 3Adenocarcinoma 3Recurrence 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Hepatocellular 2Biliary Tract Neoplasms 2Advanced Solid Tumors 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Bowel Adenocarcinoma 1

Interventions

pembrolizumab 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Gemcitabine 2somatostatin, cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)- 1sodium-iodide symporter 1fludarabine 1duvelisib 1cemiplimab 1X-Rays 1Specimen Handling 1Photons 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Disulfides 1Cyclophosphamide 1Brentuximab Vedotin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, T-Cell, Peripheral × Oxaliplatin × 30 days × Clear all
NCT04984837 2026-06-04

Study of Lacutamab in Peripheral T-cell Lymphoma

The Lymphoma Academic Research Organisation

Phase 2 Active not recruiting
49 enrolled
Lymphoid

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡